Are Katrina Victims Forgotten Already?

Hosted by
Our guest, James O-Byrne is Editor of the Living Section of the New Orleans Times-Picayune. In the aftermath of Hurricane Katrina, he-s been shaping news coverage of the recovery. He-s especially well qualified for that assignment- because he-s one of those who lost his own home. Making News: House Votes to Extend Tax BreaksDespite the increasing federal deficit, Congress yesterday completed the passage of $56 billion in tax cuts, focusing on stock dividends and capital gains. That-s a far cry from what passed the Senate, and there-s little time to reconcile their different versions before the end of the year. Jodi Schneider is Economics Editor of Congressional Quarterly. Reporter's Notebook: New England Journal of Medicine on Vioxx StudyMerck faces 6500 suits over Vioxx, the painkiller it pulled off the market. We-ll hear about other challenges facing the world-s 5th largest pharmaceutical company. The New England Journal of Medicine has published what it calls an "Expression of Concern" about Merck & Co., which took the painkiller Vioxx off the market last year. The prestigious magazine says data showing that Vioxx caused heart attacks was removed from a crucial study involving the drug. Merck says the results were "fairly and accurately" reported.
Our guest, James O-Byrne is Editor of the Living Section of the New Orleans Times-Picayune. In the aftermath of Hurricane Katrina, he-s been shaping news coverage of the recovery. He-s especially well qualified for that assignment- because he-s one of those who lost his own home.
  • Making News: House Votes to Extend Tax Breaks
    Despite the increasing federal deficit, Congress yesterday completed the passage of $56 billion in tax cuts, focusing on stock dividends and capital gains. That-s a far cry from what passed the Senate, and there-s little time to reconcile their different versions before the end of the year. Jodi Schneider is Economics Editor of Congressional Quarterly.
  • Reporter's Notebook: New England Journal of Medicine on Vioxx Study
    Merck faces 6500 suits over Vioxx, the painkiller it pulled off the market. We-ll hear about other challenges facing the world-s 5th largest pharmaceutical company. The New England Journal of Medicine has published what it calls an "Expression of Concern" about Merck & Co., which took the painkiller Vioxx off the market last year. The prestigious magazine says data showing that Vioxx caused heart attacks was removed from a crucial study involving the drug. Merck says the results were "fairly and accurately" reported.

Credits

Host:

Warren Olney